That being said, protocols whereby recombinant tau can be coaxed into forming the same fibril core structure as that seen in human AD tau fibrils have been developed by Lövestam et al. (64), albeit requiring a truncated version of tau that lacks the complexity of the full-length protein including various PTMs present in tau filaments extracted from AD brain. Here, MAPT is linked to Alzheimer disease.